Pharmaceutical serialization,
verification, and supply chain compliance.
Regulatory requirements for pharmaceutical traceability are active and enforceable across major markets. The U.S. Drug Supply Chain Security Act (DSCSA), the EU Falsified Medicines Directive (FMD), and equivalent national mandates require unit-level serialization, chain-of-custody documentation, and verification at each supply chain handoff. Authentific provides the serialization infrastructure, verification API, and compliance output layer that pharmaceutical manufacturers, wholesalers, and dispensers require to meet these obligations.
Typical pharmaceutical deployment entry points
Pharmaceutical deployments on the Authentific platform begin with one of three starting points, depending on whether the primary driver is regulatory compliance, brand protection, or fiscal marking. Most enterprise deployments combine the core platform with one or both extensions.
Authentific
Serialization and compliance core
The foundational layer for all pharmaceutical deployments. Provides unit-level serialization, the verification API, chain-of-custody event recording, and DSCSA / EU FMD compliance output generation. Every deployment starts here.
Trailio TrueBrand
Brand protection extension
Added where branded pharmaceutical products face grey-market diversion, parallel import, or unauthorized channel distribution. Extends the core platform with consumer-facing verification, diversion alerting, and counterfeit incident reporting.
Trailio TrueTax
Regulatory and fiscal extension
Applied where pharmaceutical products are subject to national excise duty, fiscal marking obligations, or government-mandated track and trace stamp programs. Adds serialized fiscal marking, government registry connectivity, and enforcement officer verification tools.
The operational and compliance risks facing pharmaceutical supply chains
Drug counterfeiting, supply chain diversion, regulatory complexity, and slow recall response are not theoretical risks. They create patient safety incidents, regulatory penalties, and supply chain liability. Each requires a different operational response — and a common infrastructure capable of supporting all of them.
Counterfeit Medicines
Counterfeit pharmaceuticals enter supply chains at multiple insertion points — including licensed distribution channels, parallel import routes, and online pharmacy networks. Products range from inert formulations to products containing hazardous substitutes for active ingredients. The patient safety risk is direct, and liability exposure for supply chain participants extends to any party that cannot demonstrate verified custody of the product.
Without unit-level serialization, it is operationally impossible to distinguish a genuine product from a high-quality counterfeit at the point of dispense. Visual inspection of packaging is not a defensible verification control.
Supply Chain Diversion and Parallel Trade
Pharmaceutical products priced or allocated for one market regularly enter unauthorized distribution channels in others. Parallel trade — legal in some jurisdictions, illegal or restricted in others — creates price erosion, supply allocation failures, and documentation gaps that complicate regulatory compliance. Diversion through secondary wholesalers and unauthorized distributors introduces products with compromised chain-of-custody into regulated supply chains.
Scan event data at every supply chain handoff makes geographic diversion detectable and evidence-grade for enforcement or contractual action.
Regulatory Compliance Complexity
DSCSA in the United States and EU FMD across EU member states impose distinct but overlapping serialization, verification, and reporting requirements. Manufacturers operating across both jurisdictions must maintain dual-format compliance outputs, manage trading partner data exchange obligations, and demonstrate audit-ready traceability for regulatory inspection. National schemes in Brazil (SNCM), China, Turkey, and other markets add further complexity for global exporters.
A fragmented serialization approach — separate systems per market — creates reconciliation overhead, data inconsistency, and audit risk. A single compliance-output platform eliminates that structural problem.
Recall Traceability Delays
Pharmaceutical recalls are time-critical. Identifying which specific units are affected, where they are in the supply chain, and which downstream trading partners hold them must be completed within hours — not days. Without unit-level serialization and real-time scan event records, recall scope identification relies on batch-level estimates that over-scope the recall and delay response.
A serialized track-and-trace system reduces recall identification to a query against the product's scan event history — precise scope, immediate result, auditable record.
DSCSA, EU FMD, and global track and trace compliance
Authentific is configured to produce compliance-ready outputs aligned with the major pharmaceutical traceability frameworks. The platform does not require custom exports or manual data transformation to meet regulatory submission requirements. Authentific aligns with GS1 global standards including SGTIN and EPCIS 2.0.
Drug Supply Chain Security Act (DSCSA)
The DSCSA requires manufacturers, wholesale distributors, repackagers, and dispensers to serialize prescription drug packages at the unit level, exchange transaction information (T3 data) at each supply chain handoff, and verify product identity at designated points in the distribution chain. The interoperability requirements of DSCSA Phase II — electronic, system-to-system data exchange — are in active enforcement.
Authentific supports DSCSA compliance through unit-level serialization aligned with GS1 standards, T3 data record generation at each chain-of-custody event, and verification API endpoints compatible with trading partner interoperability requirements.
EU Falsified Medicines Directive (FMD / Delegated Regulation 2016/161)
The EU FMD requires that all prescription medicines — and selected over-the-counter products — carry a unique identifier (2D DataMatrix), an anti-tamper device, and a serial number registered in the European Medicines Verification System (EMVS). Products must be verified at the point of dispense or decommissioned at point of supply. National Medicines Verification Organisations (NMVOs) maintain the national repositories that feed into the EMVS.
Authentific supports EU FMD compliance through serialization aligned with EU regulatory requirements, EMVS repository integration for commissioning and decommissioning events, and verification API support for dispensing point queries. The platform generates the data records required for NMVO upload in the required format.
Global pharmaceutical track and trace mandates
Beyond DSCSA and EU FMD, pharmaceutical manufacturers and exporters face serialization and traceability requirements across multiple additional jurisdictions. Brazil's SNCM, Saudi Arabia SFDA, China NMPA, Turkey ITS, and Argentina ANMAT each operate national verification programs with distinct data element requirements, encoding standards, and submission protocols.
The Authentific platform is architected to support configurable compliance output profiles per deployment market. Where a manufacturer supplies multiple markets with differing requirements, serialization can be performed once at the production line with market-specific compliance outputs generated from the same underlying identity records.
How Authentific addresses pharmaceutical supply chain requirements
The platform provides four interconnected capabilities for pharmaceutical deployments: unit-level cryptographic identity, real-time verification, end-to-end chain-of-custody traceability, and immutable event logging. Each operates as a standalone function and as part of a unified compliance record.
Unit-Level Cryptographic Identity
Every product unit receives a unique serialized identifier encoded in a cryptographically signed QR or DataMatrix code at the production line. The identifier is bound to the product's batch, lot, expiry date, and national product code at the moment of commissioning. Replication without access to the HSM-backed signing infrastructure is computationally infeasible.
Identity is issued at line speed and supported at production volumes exceeding hundreds of millions of units per deployment. Code generation does not create a serialization bottleneck at the packaging line.
Real-Time Verification
Verification queries are resolved against the Authentific identity registry in real time — from any point in the supply chain, at any location. The verification API returns a structured response: authentication status, product identity data, chain-of-custody summary, and any flags associated with the unit's scan history (duplicate scan, unexpected location, decommissioned status).
API response latency is sub-100ms under normal operating conditions. Edge-deployed verification infrastructure ensures availability in geographically distributed supply chains without central-server dependency.
End-to-End Supply Chain Traceability
Every scan event — at manufacture, wholesale receipt, secondary distribution, and point of dispense — is recorded against the unit's identity record. The resulting chain-of-custody log is complete, timestamped, and geolocation-tagged where device permissions allow. The full trace is queryable by unit, batch, lot, or date range.
Traceability records are suitable for DSCSA chain-of-custody documentation, EU FMD decommissioning verification, and recall scope identification. No post-hoc data assembly is required — the record exists and is queryable at the time of the event. See track and trace applications for full capability detail.
Immutable Event Logging
Scan events, custody transfers, verification outcomes, and exception alerts are written to an append-only event log. Records cannot be modified or deleted after creation. Each event carries a timestamp, actor identifier, location data where available, and a cryptographic reference to the associated identity record.
The immutable event log is the basis for compliance audit exports. It produces inspection-ready records for regulatory authority review without requiring manual reconstruction from multiple system sources.
Integration with pharmaceutical manufacturing and distribution infrastructure
Authentific is designed to integrate with existing enterprise systems — not to replace them. For pharmaceutical manufacturers, this means compatibility with existing ERP, MES, and packaging line infrastructure without requiring a wholesale IT replacement project.
ERP and MES Integration
Serialization order management — the allocation of serial number ranges to specific production orders, batch numbers, and packaging lines — is triggered from within the existing ERP workflow. Manufacturing Execution System (MES) integration enables real-time code issuance at the line, with batch completion confirmation and aggregation records returned to the ERP for inventory reconciliation.
Packaging Line Compatibility
The serialization code generation API is compatible with standard pharmaceutical packaging line hardware. Direct print via industrial inkjet or laser marking, label print-and-apply, and integrated vision system verification are all supported configurations. Camera-based vision system integration enables real-time code readability confirmation and rejected-unit logging during packaging operations.
Serialization Workflows
Production-to-ship workflows cover the full serialization lifecycle: code commissioning at manufacture, aggregation at case and pallet level, shipping notification to trading partners, receipt confirmation at wholesale, and decommissioning at dispense. Each workflow step can be triggered via API, mobile scan app, or direct ERP system call, depending on the operational context of the trading partner.
ERP Connectors
Pre-built integration support for SAP, Oracle, and Microsoft Dynamics environments. Custom connector development for other platforms via documented API.
Line Interface
SOAP, REST, and ANSI-MH10 data interfaces for packaging line connectivity. Supports both push and pull serialization models.
Aggregation Engine
Automated unit-to-case-to-pallet parent-child relationship management. SSCC generation and GS1-128 barcode support for logistics integration.
Trading Partner Exchange
EPCIS 2.0 event sharing via AS2, SFTP, or direct API for supply chain partner data exchange. DSCSA-aligned T3 data package generation.
How different supply chain participants use the platform
The Authentific pharmaceutical deployment serves four distinct actor types across the supply chain. Each has different access permissions, data visibility, and workflow requirements — all served from the same deployment.
Manufacturer Serialization and Verification
Manufacturers serialize at the production line, aggregate to case and pallet, and generate the shipping notification records required for downstream trading partner receipt. The platform handles code commissioning, vision system integration, rejected-unit decommissioning, and outbound EPCIS dispatch advice generation. Compliance output files for DSCSA T3 and EMVS commissioning are generated automatically at batch close.
Wholesale Distributor Validation and Custody Transfer
Wholesale distributors scan inbound shipments at receipt to verify that serialized units match the trading partner's advance ship notice, have valid identity records, and have not been previously decommissioned or flagged as suspect. Custody transfer events are recorded in the platform and are available to the next downstream trading partner. Suspect product holds are supported with exception workflow management.
Point-of-Dispense Pharmacy Authentication
At the point of dispense, the pharmacy's system queries the Authentific verification API with the product's serialized identifier. The response confirms whether the product is authentic, active, and has not been previously decommissioned. For EU FMD deployments, the successful verification triggers the decommissioning event in the NMVO repository. The API integrates directly with pharmacy management systems without requiring a separate verification device.
Regulatory Inspection and Compliance Audit
During a regulatory inspection or supply chain audit, inspectors and compliance teams can query the platform for a complete traceability report for any serialized unit or batch. The report includes every custody event, scan location, verification outcome, and exception flag recorded against the unit from manufacture to its current status. Compliance audit exports are formatted for direct submission to regulatory authorities.
How Authentific, TrueBrand, and TrueTax map to pharmaceutical requirements
The Authentific platform serves as the core identity and traceability infrastructure for pharmaceutical deployments. Depending on the commercial and regulatory scope of the engagement, two product extensions — Trailio TrueBrand and Trailio TrueTax — can be deployed alongside the core platform to address brand protection and regulatory excise requirements respectively.
Authentific
Core identity infrastructure
Authentific is the foundational layer for all pharmaceutical deployments. It provides the serialization engine, the cryptographic identity per unit, the verification API, the scan event infrastructure, and the compliance output layer. Every pharmaceutical deployment — regardless of scope — begins with the Authentific core platform.
Trailio TrueBrand
Brand protection and authentication layer
For pharmaceutical manufacturers who need brand protection capabilities alongside regulatory compliance, TrueBrand extends the core platform with consumer-facing authentication, market diversion monitoring, and supply chain anomaly alerting. This is particularly relevant for high-value branded drugs where grey-market diversion and unauthorized channel entry represent both regulatory and commercial risks.
Trailio TrueTax
Regulatory and excise extension
In markets where pharmaceutical products are subject to excise duty, fiscal marking requirements, or government-mandated tax stamp programs — such as certain OTC medicines, controlled substances with fiscal classification, or medicinal products in specific national tax regimes — TrueTax extends the Authentific deployment with serialized fiscal marking infrastructure, government registry connectivity, and enforcement officer verification tools.
Note on platform scope: All pharmaceutical deployments begin with the Authentific core platform. TrueBrand and TrueTax are additive extensions deployed where the commercial and regulatory scope requires them — not mandatory components of every pharmaceutical engagement. A solutions engineer will scope the appropriate deployment configuration for your specific market, regulatory obligations, and operational environment.
Platform capabilities relevant to pharmaceutical deployments
Track & Trace
End-to-end chain-of-custody recording across the full pharmaceutical distribution network. Recall-ready and compliance-auditable from manufacture to dispense.
Explore Track & Trace →Platform Technology
Cryptographic QR infrastructure, HSM-backed key management, and edge verification architecture. How the identity layer works at an engineering level.
Explore Technology →Industries Overview
Pharmaceuticals is one of seven sectors where Authentific is deployed. See how the same platform is configured for FMCG, government excise, and regulated industrial environments.
View All Industries →Evaluate Authentific for your pharmaceutical serialization and compliance requirements.
A solutions engineer will assess your specific deployment context — regulatory markets, production volumes, existing ERP and MES infrastructure, trading partner exchange obligations, and compliance output requirements — in a single structured session. No generic sales presentation. A direct, technical evaluation.